IP02-30: Development of a Machine Learning-Driven, Nanoscale Imaging Platform for Non-invasive Bladder Cancer Diagnosis in a Prospective, Cross-sectional, Case-Controlled Study

IP02-30: Development of a Machine Learning-Driven, Nanoscale Imaging Platform for Non-invasive Bladder Cancer Diagnosis in a Prospective, Cross-sectional, Case-Controlled Study

Friday, May 15, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!